134 related articles for article (PubMed ID: 36272615)
1. Mutant p53 driven-LINC00857, a protein scaffold between FOXM1 and deubiquitinase OTUB1, promotes the metastasis of pancreatic cancer.
Zhang W; Qian W; Gu J; Gong M; Zhang W; Zhang S; Zhou C; Jiang Z; Jiang J; Han L; Wang X; Wu Z; Ma Q; Wang Z
Cancer Lett; 2023 Jan; 552():215976. PubMed ID: 36272615
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis.
Chen P; Zeng Z; Wang J; Cao W; Song C; Lei S; Li Y; Ren Z
Cell Death Discov; 2022 Apr; 8(1):198. PubMed ID: 35418193
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
[TBL] [Abstract][Full Text] [Related]
4. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R
Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807
[TBL] [Abstract][Full Text] [Related]
5. Broussoflavonol B from
Jeong JH; Ryu JH
Molecules; 2020 May; 25(10):. PubMed ID: 32429421
[TBL] [Abstract][Full Text] [Related]
6. OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance.
Karunarathna U; Kongsema M; Zona S; Gong C; Cabrera E; Gomes AR; Man EP; Khongkow P; Tsang JW; Khoo US; Medema RH; Freire R; Lam EW
Oncogene; 2016 Mar; 35(11):1433-44. PubMed ID: 26148240
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein.
Liu M; Zhong J; Zeng Z; Huang K; Ye Z; Deng S; Chen H; Xu F; Li Q; Zhao G
Theranostics; 2019; 9(16):4795-4810. PubMed ID: 31367258
[No Abstract] [Full Text] [Related]
8. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1.
Chen L; Xu Z; Li Q; Feng Q; Zheng C; Du Y; Yuan R; Peng X
Cell Death Dis; 2021 Sep; 12(10):887. PubMed ID: 34584067
[TBL] [Abstract][Full Text] [Related]
9. CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1.
Mao L; Le S; Jin X; Liu G; Chen J; Hu J
Exp Cell Res; 2019 Jan; 374(2):274-281. PubMed ID: 30352219
[TBL] [Abstract][Full Text] [Related]
10. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression.
Zhu J; Zhao J; Luo C; Zhu Z; Peng X; Zhu X; Lin K; Bu F; Zhang W; Li Q; Wang K; Hu Z; Yu X; Chen L; Yuan R
Cell Death Dis; 2022 May; 13(5):497. PubMed ID: 35614040
[TBL] [Abstract][Full Text] [Related]
11. OTUB1-catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer.
Wang Y; Zhou X; Xu M; Weng W; Zhang Q; Yang Y; Wei P; Du X
Oncotarget; 2016 Jun; 7(24):36681-36697. PubMed ID: 27167337
[TBL] [Abstract][Full Text] [Related]
12. m
Meng X; Deng Y; He S; Niu L; Zhu H
Front Oncol; 2021; 11():629947. PubMed ID: 33680969
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional Repression by FoxM1 Suppresses Tumor Differentiation and Promotes Metastasis of Breast Cancer.
Kopanja D; Chand V; O'Brien E; Mukhopadhyay NK; Zappia MP; Islam ABMMK; Frolov MV; Merrill BJ; Raychaudhuri P
Cancer Res; 2022 Jul; 82(13):2458-2471. PubMed ID: 35583996
[TBL] [Abstract][Full Text] [Related]
14. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer.
Hu Y; Wang F; Xu F; Fang K; Fang Z; Shuai X; Cai K; Chen J; Hu P; Chen D; Xu P; Hu C; Zeng Z; Zhong J; Li W; Tang J; Huang M; Zhao Y; Wang C; Zhao G
Theranostics; 2020; 10(22):10120-10140. PubMed ID: 32929338
[No Abstract] [Full Text] [Related]
15. Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer.
Zhou Z; Chen H; Xie R; Wang H; Li S; Xu Q; Xu N; Cheng Q; Qian Y; Huang R; Shao Z; Xiang M
Mol Oncol; 2019 Apr; 13(4):873-893. PubMed ID: 30628173
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1.
Yi J; Li H; Chu B; Kon N; Hu X; Hu J; Xiong Y; Kaniskan HU; Jin J; Gu W
Cell Death Differ; 2023 Jul; 30(7):1799-1810. PubMed ID: 37291217
[TBL] [Abstract][Full Text] [Related]
17. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
Millour J; de Olano N; Horimoto Y; Monteiro LJ; Langer JK; Aligue R; Hajji N; Lam EW
Mol Cancer Ther; 2011 Jun; 10(6):1046-58. PubMed ID: 21518729
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
[TBL] [Abstract][Full Text] [Related]
19. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.
Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K
Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
